Delivery Order SPE2DB24D2205-SPE2DB24FDZAQ

Award Date 8/26/24
Potential Completion Date 9/17/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $13,455.60, is for the delivery of GAMMAGARD S-D 10 G (IGA pharmaceutical products. The contract was awarded on a Firm Fixed Price basis and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $8,625.24 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply GAMMAGARD S-D 10 G (IGA. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all work completed by November 27, 2023. No set-aside designation was applied to this order, which was issued against an indefinite delivery contract held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $115,417.92 firm-fixed-price contract is for the supply of GAMUNEX-C 40 gram/400 mL vials, a specialized immunoglobulin medication. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the drug GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The $29,851.68 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on December 4, 2024 with a completion date of December 26, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,161.68, is for the delivery of GAMUNEX-C 20 gram/200 ml vials, a pharmaceutical product, with a completion date of May 1, 2025. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This federal contract award is for the delivery of GAMUNEX-C 20 gram/200 ml vials to the Defense Logistics Agency (DLA). The $42,885.00 firm-fixed-price delivery order was awarded on May 28, 2024 to Amerisourcebergen Drug Corp's Corporate Office Division, with a completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $49,752.80 for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 5 gram/50 ml vial. The order has a firm fixed price of $2,959.30 and a period of performance through September 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to deliver a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price of $9,618.16 and a completion date of August 26, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,327.20, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product. The contract is a firm fixed price delivery order with a completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDZAQ
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,485.20 firm-fixed-price contract is for the supply of GAMMAGARD S-D 10 G (IGA), a specialty pharmaceutical product. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen Drug Corp is a large for-profit organization that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range of pharmaceutical and medical supplies. This delivery order is part of the company's broader support for the medical needs of military treatment facilities, veterans' hospitals, and other federal healthcare providers nationwide. The contract does not have a set-aside designation.

Generated 11/25/24, 9:11 AM